BiotechTubeBiotechTube
Home/CG Oncology/Jim Mulé
JM

Jim Mulé

Director of Cell-based Therapies, Moffitt Cancer Center (Board of Directors)

CG Oncology

Therapeutic Areas

OncologyUrologic Oncology

CG Oncology Pipeline

DrugIndicationPhase
Cretostimogene grenadenorepvecBCG-unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) with Carcinoma in Situ (CIS)Phase 3

Leadership Team at CG Oncology

AK
Arthur Kuan
Chairman & Chief Executive Officer
AB
Ambaw Bellete
President & Chief Operating Officer
VK
Vijay Kasturi
Chief Medical Officer
SB
Swapnil Bhargava
Chief Technical Officer
JP
Josh Patterson
General Counsel & Chief Compliance Officer
SE
Susan E. Graf
Senior Advisor & Entrepreneur in Residence, Locust Walk (Board of Directors)
BL
Brian Liu
Managing Director, Longitude Capital (Board of Directors)
LP
Leonard Post
Chief Scientific Officer, Vivace Therapeutics (Board of Directors)
CR
Christina Rossi
Biopharmaceutical Executive & Board Member (Board of Directors)
VT
Victor Tong, Jr.
Managing Director, Decheng Capital (Board of Directors)
View full CG Oncology profile